These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Rapid control of a chancroid outbreak: implications for Canada. Jessamine PG; Brunham RC CMAJ; 1990 May; 142(10):1081-5. PubMed ID: 2337844 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology of chancroid and Haemophilus ducreyi in Nairobi, Kenya. Plummer FA; D'Costa LJ; Nsanze H; Dylewski J; Karasira P; Ronald AR Lancet; 1983 Dec; 2(8362):1293-5. PubMed ID: 6139629 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand. Taylor DN; Pitarangsi C; Echeverria P; Panikabutra K; Suvongse C J Infect Dis; 1985 Nov; 152(5):1002-6. PubMed ID: 3876396 [TBL] [Abstract][Full Text] [Related]
5. Chancroid epidemiology in New Orleans men. DiCarlo RP; Armentor BS; Martin DH J Infect Dis; 1995 Aug; 172(2):446-52. PubMed ID: 7622888 [TBL] [Abstract][Full Text] [Related]
6. Haemophilus ducreyi infection in south Florida: a rare disease on the rise? Becker TM; DeWitt W; Van Dusen G South Med J; 1987 Feb; 80(2):182-4. PubMed ID: 3492766 [TBL] [Abstract][Full Text] [Related]
7. 2017 European guideline for the management of chancroid. Lautenschlager S; Kemp M; Christensen JJ; Mayans MV; Moi H Int J STD AIDS; 2017 Mar; 28(4):324-329. PubMed ID: 28081686 [TBL] [Abstract][Full Text] [Related]
8. Chancroid and granuloma inguinale. Ronald AR; Plummer FA Clin Lab Med; 1989 Sep; 9(3):535-43. PubMed ID: 2676322 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology, clinical features, diagnosis and treatment of Haemophilus ducreyi - a disappearing pathogen? Lewis DA Expert Rev Anti Infect Ther; 2014 Jun; 12(6):687-96. PubMed ID: 24597521 [TBL] [Abstract][Full Text] [Related]
10. Treatment of chancroid. A comparison of sulphamethoxazole and trimethoprim-sulphamethoxazole. Fast MV; Nsanze H; Plummer FA; D'Costa LJ; MacLean IW; Ronald AR Br J Vener Dis; 1983 Oct; 59(5):320-4. PubMed ID: 6351957 [TBL] [Abstract][Full Text] [Related]
11. Epidemiologic, clinical, laboratory, and therapeutic features of an urban outbreak of chancroid in North America. Hammond GW; Slutchuk M; Scatliff J; Sherman E; Wilt JC; Ronald AR Rev Infect Dis; 1980; 2(6):867-79. PubMed ID: 6971469 [TBL] [Abstract][Full Text] [Related]
13. Chancroidal ulcers that are not chancroid. Cause and epidemiology. Salzman RS; Kraus SJ; Miller RG; Sottnek FO; Kleris GS Arch Dermatol; 1984 May; 120(5):636-9. PubMed ID: 6326691 [TBL] [Abstract][Full Text] [Related]
14. Short-course and single-dose antimicrobial therapy for chancroid in Kenya: studies with rifampin alone and in combination with trimethoprim. Plummer FA; Nsanze H; D'Costa LJ; Ndugga Maggwa AB; Girouard Y; Karasira P; Albritton WL; Ronald AR Rev Infect Dis; 1983; 5 Suppl 3():S565-72. PubMed ID: 6635447 [TBL] [Abstract][Full Text] [Related]
15. A case of mixed chancre. Falk ES; Vorland LH; Bjorvatn B Dermatologica; 1984; 168(1):47-9. PubMed ID: 6607850 [TBL] [Abstract][Full Text] [Related]
16. Leads from the MMWR. Chancroid--Massachusetts. JAMA; 1986 Apr; 255(13):1673-4. PubMed ID: 3485202 [No Abstract] [Full Text] [Related]
17. Antimicrobial therapy of chancroid: an evaluation of five treatment regimens correlated with in vitro sensitivity. Fast MV; Nsanze H; D'Costa LJ; Karasira P; Maclean IW; Piot P; Albritton WL; Ronald AR Sex Transm Dis; 1983; 10(1):1-6. PubMed ID: 6601847 [TBL] [Abstract][Full Text] [Related]
19. Emergence of Haemophilus ducreyi resistance to trimethoprim-sulfamethoxazole in Rwanda. Van Dyck E; Bogaerts J; Smet H; Tello WM; Mukantabana V; Piot P Antimicrob Agents Chemother; 1994 Jul; 38(7):1647-8. PubMed ID: 7979300 [TBL] [Abstract][Full Text] [Related]
20. Chancroid: results from an outbreak in Houston, Texas. Jones C; Rosen T; Clarridge J; Collins S South Med J; 1990 Dec; 83(12):1384-9. PubMed ID: 2251526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]